AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
NovaBay Pharmaceuticals Declares Special Cash Dividend, Stock Soars
ByAinvest
Wednesday, Aug 27, 2025 2:06 pm ET1min read
NovaBay Pharmaceuticals has declared a special cash dividend of $0.80 per share, payable on September 29 to holders of record on September 15. The stock has gained 76.32% in the last 5 days and 167.67% in the first year.
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) has announced a significant move in its shareholder value strategy by declaring a one-time special cash dividend of $0.80 per share. The dividend, payable on September 29, 2025, is available to shareholders of record as of September 15, 2025 [1][2][3].The special dividend reflects NovaBay's commitment to returning value to its stockholders. The company's CEO, David Lazar, expressed excitement about the future, noting that the dividend is part of the company's strategic alternatives exploration [1][2].
Due to the substantial nature of the dividend, representing more than 25% of the company's common stock price, NYSE American has advised that the stock will trade with "due bills" during the Dividend Right Period, from September 15, 2025, through September 29, 2025 [1][2]. Stockholders selling their shares during this period will not be entitled to receive the dividend.
In addition to the dividend, NovaBay has shown strong financial performance. In the latest half-year period, the company's net profit exceeded that of the previous twelve months, and inventory turnover and debtors turnover ratios have improved significantly [3]. These indicators suggest that NovaBay is effectively managing its operations and inventory, which may lead to improved profit margins.
The stock has seen remarkable growth, increasing by 76.32% in the last five days and 167.67% in the first year. This growth, coupled with the special dividend, underscores the company's potential and investor interest [1][2].
Investors should consult their brokers to understand the implications of the due bill procedures and ensure they are aware of the dividend rights [1][2]. Forward-looking statements in the announcement should be reviewed with caution, as they are subject to risks and uncertainties [1][2].
References:
[1] https://www.barchart.com/story/news/34403142/novabay-pharmaceuticals-announces-one-time-special-cash-dividend-of-0-80-per-share
[2] https://seekingalpha.com/news/4489315-novabay-declares-0_80-dividend
[3] https://www.marketsmojo.com/stocks-analysis/recommendation/novabay-pharmaceuticals-inc-1158331-215
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet